A 2-year point-prevalence surveillance of healthcare-associated infections and antimicrobial use in Ferrara University Hospital, Italy

BMC Infectious Diseases - Tập 20 - Trang 1-8 - 2020
Paola Antonioli1, Niccolò Bolognesi2, Giorgia Valpiani3, Chiara Morotti3, Daniele Bernardini2, Francesca Bravi3, Eugenio Di Ruscio4, Armando Stefanati5, Giovanni Gabutti5
1Department of Hospital Hygiene & Healthcare-Associated Infection Risk Management, Hospital Health Medical Management, S. Anna University Hospital of Ferrara, Ferrara, Italy
2Postgraduate School of Hygiene and Preventive Medicine, University of Ferrara, Ferrara, Italy
3Research Innovation Quality and Accreditation Unit, S. Anna University Hospital of Ferrara, Ferrara, Italy
4Medical Director, S. Anna University Hospital of Ferrara, Ferrara, Italy
5Department of Medical Sciences, University of Ferrara, Ferrara, Italy

Tóm tắt

Healthcare-Associated Infections (HAIs) represent one of the leading issues to patient safety as well as a significant economic burden. Similarly, Antimicrobial Use (AMU) and Resistance (AMR) represent a growing threat to global public health and the sustainability of healthcare services. A Point Prevalence Survey (PPS) following the 2016 ECDC protocol for HAI prevalence and AMU was conducted at Ferrara University Hospital (FUH). Data were collected by a team of trained independent surveyors in 2016 and 2018. Risk factors independently associated with HAI were assessed by a multivariate logistic regression model. Of the 1102 patients surveyed, 115 (10.4%) had an active HAI and 487 (44.2%) were on at least 1 systemic antimicrobial agent. Factors independently associated with increased HAI risk were a “Rapidly Fatal” McCabe score (expected fatal outcome within 1 year), presence of medical devices (PVC, CVC, indwelling urinary catheter or mechanically assisted ventilation) and a length of hospital stay of at least 1 week. The most frequent types of HAI were pneumonia, bloodstream infections, and urinary tract infections. Antimicrobial resistance to third-generation cephalosporins was observed in about 60% of Enterobacteriaceae. The survey reports a high prevalence of HAI and AMU in FUH. Repeated PPSs are useful to control HAIs and AMU in large acute-care hospitals, highlighting the main problematic factors and allowing planning for improvement actions.

Tài liệu tham khảo

Agency for Healthcare Research and Quality (U.S. Department of Health & Human Services). Health Care-Associated Infections 2018. https://www.ahrq.gov/professionals/quality-patient-safety/patient-safety-resources/resources/hais/index.html (accessed 22 January 2019). European Centre for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. Stockholm: ECDC: 2013. doi:https://doi.org/10.2900/86011. European Centre for Disease Prevention and Control. Annual Epidemiological Report 2012. Reporting on 2010 surveillance data and 2011 epidemic intelligence data. Stockholm: ECDC: 2013. Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank H-P, Ducomble T, et al. Burden of six healthcare-associated infections on European population health: estimating incidence-based disability-adjusted life years through a population prevalence-based Modelling study. PLoS Med. 2016;13:e1002150. https://doi.org/10.1371/journal.pmed.1002150. Cassini A, Colzani E, Pini A, Mangen MJJ, Plass D, McDonald SA, et al. Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the burden of communicable diseases in Europe study, European Union and European economic countries, 2009 to 2013. Eurosurveillance. 2018;23:1–20. https://doi.org/10.2807/1560-7917.ES.2018.23.16.17-00454. Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, et al. Health care–associated infections. JAMA Intern Med. 2013;173:2039. https://doi.org/10.1001/jamainternmed.2013.9763. Istituto Superiore di Sanita. Infezioni correlate all’assistenza aspetti epidemiologici [Istituto Superiore di Sanità - Healthcare Associated Infections, epidemiological aspects] https://www.epicentro.iss.it/infezioni-correlate/epidemiologia (accessed 7 March 2019). Italian. WHO. Antimicrobial resistance 2018. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance (accessed 22 January 2019). Ramos-Castañeda JA, Ruano-Ravina A, Barbosa-Lorenzo R, Paillier-Gonzalez JE, Saldaña-Campos JC, Salinas DF, et al. Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: systematic review and meta-analysis: mortality due to KPC Klebsiella pneumoniae infections. J Inf Secur. 2018;76:438–48. https://doi.org/10.1016/j.jinf.2018.02.007. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. https://apps.who.int/iris/bitstream/handle/10665/259462/9789241550178-eng.pdf;jsessionid=F0D861E42F91D8D48293FE5D30F99D75?sequence=1 (accessed 25 September 2019). Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19:56–66. https://doi.org/10.1016/S1473-3099(18)30605-4. European Centre for Disease Prevention and Control. Antimicrobial consumption. In: ECDC. Annual epidemiological report for 2017. Stockholm: ECDC; 2018. http://ecdc.europa.eu/sites/portal/files/documents/AER_for_2017-antimicrobial-consumption.pdf (). Suetens C, Latour K, Kärki T, Ricchizzi E, Kinross P, Moro ML, et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill. 2018;23:15–28. https://doi.org/10.2807/1560-7917.ES.2018.23.46.1800516. Moro ML, Ciofi Degli Atti M, D’Amore C, Diegoli G, Forni S, Gagliotti C, et al. Good practices for the surveillance and control of antimicrobial resistance. Epidemiol Prev. 2019;43:185–93. https://doi.org/10.19191/EP19.2-3.P185.058. Secondo studio di prevalenza italiano sulle infezioni correlate all’assistenza e sull’uso di antibiotici negli ospedali per acuti - Protocollo ECDC. Dipartimento Scienze della Salute Pubblica e Pediatriche Università di Torino. 2018. http://www.salute.gov.it/imgs/C_17_pubblicazioni_2791_allegato.pdf (accessed 25 September 2019). Antonioli P, Manzalini MC, Stefanati A, Bonato B, Verzola A, Formaglio A,Gabutti G. Temporal trends of healthcare associated infections and antimicrobial use in 2011-2013, observed with annual point prevalence surveys in Ferrara University hospital, Italy J Prev Med Hyg 2016;57(3):E135-E141. Review. PubMed PMID: 27980377; PubMed Central PMCID: PMC5139608. Antonioli P, Formaglio A, Gamberoni D, Bertoni L, Perrone P, Stefanati A, et al. Hospital discharge in patients at risk of surgical site infection: antimicrobial stewardship at Ferrara University hospital, Italy. J Prev Med Hyg. 2018;59:E139–44. WHO. WHO Guidelines on Hand Hygiene in Health Care 2009. https://www.who.int/gpsc/5may/tools/9789241597906/en/ (accessed 6 March 2019). Antonioli P, Manzalini M, Bolognesi N, Martellucci C, Cudini E, Di Ruscio E, et al. Aim to improve safety and empowerment in surgery: what to do to get ready for the best. Clin Heal Promot. 2019;vol. 9(Warsaw):18 https://www.hphconferences.org/fileadmin/user_upload/conferences/Warsaw2019/Abstractbook_2019_Warsaw.pdf / ( ECDC. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals - protocol version 5.3. Stockholm: ECDC: 2016. http://ecdc.europa.eu/sites/portal/files/documents/PPS-HAI-AMR-protocol.pdf (accessed 25 September 2019). McCabe WR, Jackson GG. Gram-negative bacteremia. Arch Intern Med. 1962;110:847. https://doi.org/10.1001/archinte.1962.03620240029006. WHO Collaborating Centre for Drug Statistic Methodology. ATC/DDD Index 2019 2019. https://www.whocc.no/atc_ddd_index/ (accessed 30 January 2019). Hosmer DW, Lemeshow S. Applied logistic regression. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2000. https://doi.org/10.1002/0471722146. Metsini A, Vazquez M, Sommerstein R, Marschall J, Voide C, Troillet N, Gardiol C, Pittet D, Zingg W, The Swissnoso network. Point prevalence of healthcare-associated infections and antibiotic use in three large Swiss acute-care hospitals Swiss Med Wkly 2018;148:w14617. doi: https://doi.org/10.4414/smw.2018.14617. eCollection 2018. PubMed PMID: 29698542. Cai Y, Venkatachalam I, Tee NW, Tan TY, Kurup A, Wong SY, et al. Prevalence of healthcare-associated infections and antimicrobial use among adult inpatients in Singapore acute-care hospitals: results from the first National Point Prevalence Survey. Clin Infect Dis. 2017;64:S61–7. https://doi.org/10.1093/cid/cix103. Loveday HP, Wilson JA, Pratt RJ, Golsorkhi M, Tingle A, Bak A, et al. Epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect. 2014;86(Suppl 1):S1–70. https://doi.org/10.1016/S0195-6701(13)60012-2. Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:625–63. https://doi.org/10.1086/650482. Tenke P, Kovacs B, Bjerklund Johansen TE, Matsumoto T, Tambyah PA, Naber KG. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents. 2008;31:68–78. https://doi.org/10.1016/j.ijantimicag.2007.07.033. Lo E, Nicolle LE, Coffin SE, Gould C, Maragakis LL, Meddings J, et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35:464–79. https://doi.org/10.1086/675718. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of clostridium difficile infections. Am J Gastroenterol. 2013;108:478–98. https://doi.org/10.1038/ajg.2013.4. Valiquette L, Cossette B, Garant M-P, Diab H, Pépin J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the Hypervirulent NAP1/027 strain. Clin Infect Dis. 2007;45:S112–21. https://doi.org/10.1086/519258. Climo MW, Israel DS, Wong ES, Williams D, Coudron P, Markowitz SM. Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost. Ann Intern Med. 1998;128:989–95. Wilcox MH, Freeman J, Fawley W, MacKinlay S, Brown A, Donaldson K, et al. Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea. J Antimicrob Chemother. 2004;54:168–72. https://doi.org/10.1093/jac/dkh285. Institute of Medicine (US) Committee on Quality of Health Care in America; Kohn LT, Corrigan JM, Donaldson MS, editors. To Err is Human: Building a Safer Health System. Washington (DC): National Academies Press (US); 2000. PubMed PMID: 25077248. Saleem Z, Hassali MA, Godman B, Hashmi FK, Saleem F. A multicenter point prevalence survey of health care–associated infections in Pakistan: findings and implications. Am J Infect Control 2019;47(4):421–424. doi: https://doi.org/10.1016/j.ajic.2018.09.025. Epub 2018 Nov 22. PubMed PMID: 30471976